ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,150, issued on Sept. 15, was assigned to SOCIETE DES PRODUITS NESTLE S.A. (Vevey, Switzerland) and LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (Zurich).

"Compositions and methods for increasing T cell function" was invented by Nicola Vannini (La Croix, Switzerland), George Coukos (Chexbres, Switzerland), Serge Andre Dominique Rezzi (Semsales, Switzerland), Julie Laval (Caux, France), Caroline Monnard (Cheseaux-sur-Lausanne, Switzerland) and Marcela Rincon Restrepo (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "An agent for use in reducing T cell exhaustion and/or increasing T cell function, and/or boosting immunity, wherein the ...